Skip to main content

Psoriatic Arthritis News

In a recent study, researchers investigated the association between gluten consumption and risk for developing psoriasis, psoriatic arthritis, and atopic dermatitis.
Fatigue is a common and debilitating symptom among patients with psoriatic arthritis. In a recent study, researchers identified multiple clinical and disease-related factors that contribute to fatigue in this patient population.
A recent systematic review compared the safety and efficacy of several biologics and disease-modifying antirheumatic drugs (DMARDS) for the treatment of active psoriatic arthritis among patients who were biologic-naïve or experienced.
In a recent study, researchers examined whether higher body mass index affected response to abatacept among patients with psoriatic arthritis.
Findings from a recent study presented at the EULAR 2019 highlighted the risk for certain cancers among patients with psoriatic arthritis treated with tumor necrosis factor inhibitors.
A recent study showed increases in serum lipid levels among patients with psoriatic arthritis treated with a Janus kinase inhibitor; however, cardiovascular adverse events were low.
Findings from a recent study showed long term treatment of psoriasis with an oral molecule was associated with maintenance of clinical benefit and no new safety signals.
Researchers assessed whether comorbidity burden affected physical function among patients with psoriatic arthritis compared with those with ankylosing spondylitis.
A recent study investigated whether patients with psoriatic arthritis who switched to a biosimilar maintained low disease activity.
After reviewing the evidence, the National Psoriasis Foundation’s medical board released recommendations for the recombinant herpes zoster vaccine for patients with psoriasis and psoriatic arthritis.
Back to Top